Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Vortioxetine-d8
Price:
Purity: 99.0%
Stocking Period: 10 Day
Contact: Yang

2140316-62-5

2140316-62-5 structure

Name: Vortioxetine-d8
Chemical Name: Vortioxetine D8
CAS Number: 2140316-62-5
Molecular Formula: C₁₈H₁₄D₈N₂S
Molecular Weight: 306.49
Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
Create Date: 2020-01-23 19:25:51
Modify Date: 2024-01-12 06:26:29
Vortioxetine D8 is a deuterium labeled Vortioxetine. Vortioxetine is an inhibitor of 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT, with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively[1][2][3][4][5].

Name	Vortioxetine D8

Description	Vortioxetine D8 is a deuterium labeled Vortioxetine. Vortioxetine is an inhibitor of 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT, with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively[1][2][3][4][5].
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> Neuronal Signaling >> Serotonin Transporter Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor
References	[1]. Bang-Andersen B, Ruhland T, J rgensen M, Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem. 2011 May 12;54(9):3206-21. [2]. Guilloux JP, Mendez-David I, Pehrson A, Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology. 2013 May 28;73C:147-159. [3]. Theunissen EL, Street D, H?jer AM, A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition. Clin Pharmacol Ther. 2013 Jun;93(6):493-501. [4]. Rothschild AJ, Mahableshwarkar AR, Jacobsen P, Vortioxetine (Lu AA21004) 5mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States. Eur Neuropsychopharmacol. 2012 Dec;22(12):858-66. [5]. Mørk A, Pehrson A, Brennum LT, Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. J Pharmacol Exp Ther. 2012 Mar;340(3):666-75.

Molecular Formula	C₁₈H₁₄D₈N₂S
Molecular Weight	306.49

2140316-62-5	1815608-51-5
1639263-80-1	960203-27-4
508233-77-0	508233-75-8
1011-14-9	1928741-88-1
508233-74-7	2476761-84-7
1158522-08-7	940364-43-2
134104-43-1	131615-57-1
922027-76-7	6906-52-1
886923-10-0	930439-75-1
1018584-77-4	1375289-11-4